Delaware SB319 mandates coverage for diagnostic services and treatment for menopause, perimenopause, and related symptoms in health insurance.
Delaware SB319 amends state law to require health insurance policies to cover diagnostic services and treatment for menopause, perimenopause, and related symptoms. This includes hormonal therapies, non-hormonal treatments, behavioral health care services, and bone health treatments. Hormone replacement therapy cannot be denied or limited if supported by clinical guidelines. Insurers must provide clear information about these services. The law applies to policies issued, renewed, or modified after December 31, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.